This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
Visit of Prof. Bréchet to northern france branch of the CEA to discuss relationships with local actors in research and innovation
OncoThAI researchers presented their latest works during the ASLMS 2018 conference in Dallas
OncoThAI work reported in the French weekly journal Le Point (April 5th, 2018)
Page 3 of 7